TB Multimedia Resources
The high-resolution, public domain visuals below are available for use in your publication. This page will be updated as new media resources become available.
If you need more information about the data connected to the release, please click the more information button to find accompanying press releases, articles, and reports.
CDC released updated recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) for treatment of latent TB infection. The updated recommendations support expanded use of an effective, shorter, treatment regimen to reach even more people with latent TB infection.
Preliminary data show that while TB case counts reached a record low in 2017, the rate of decline is too slow to eliminate TB during this century.
Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR).